Doctor's Guide to Medical & Other News


To print: Select File and then Print from your browser's menu
---------------------------------------------------------------------------------------
Title: Norditropin Gets EU Approval For Growth Hormone Disorders
URL: http://www.pslgroup.com/dg/12BEB2.htm
Doctor's Guide
September 15, 1999


BAGSVAERD, DENMARK -- September 15, 1999 -- Novo Nordisk A/S announced today that it has received mutual recognition for approval of its liquid growth hormone, Norditropin® SimpleXx™ in the EU, via the Danish health authorities.

This is the first liquid growth hormone to be launched with a dedicated pen system (NordiPen™).

Lars Rebien Sorensen, corporate executive vice president in charge of Novo Nordisk Health Care, said: "With the launch of Norditropin SimpleXx we establish Novo Nordisk as the logical first choice for hospitals and doctors treating growth hormone related disorders. We will have the broadest line of products and advanced pen systems that match the needs of each individual patient - an offer which cannot be matched by any other company."

Launch in a number of European countries will take place during 1999/2000. The product was filed in Japan and the US earlier this year.

Related Links: Norditropin.

---------------------------------------------------------------------------------------------
Copyright © 1999 P\S\L Consulting Group Inc. All rights reserved. Republication or redistribution of P\S\L content is expressly prohibited without the prior written consent of P\S\L. P\S\L shall not be liable for any errors, omissions or delays in this content or any other content on its sites, newsletters or other publications, nor for any decisions or actions taken in reliance on such content.
---------------------------------------------------------------------------------------------
This news story was printed from *Doctor's Guide to the Internet*
located at http://www.docguide.com
---------------------------------------------------------------------------------------

Return to News Story Page


This site is maintained by webmaster@pslgroup.com
Please contact us with any comments, problems or bugs.
All contents Copyright (c) 1998 P\S\L Consulting Group Inc.
All rights reserved.